Iopamidol

Basic Information

Item Value
DrugBank ID DB08947
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 74

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 Prinzmetal angina KG + DL
2 female breast carcinoma KG + DL
3 migraine with brainstem aura KG + DL
4 migraine disorder KG + DL
5 tendinitis KG + DL
6 idiopathic granulomatous myositis KG + DL
7 myositis fibrosa KG + DL
8 hemoglobinopathy KG + DL
9 pulmonary hypertension KG + DL
10 fibromyalgia KG + DL
11 kyphoscoliotic heart disease KG + DL
12 antithrombin deficiency type 2 KG + DL
13 homozygous familial hypercholesterolemia KG + DL
14 inclusion body myositis KG + DL
15 partial deletion of the short arm of chromosome 16 KG + DL
16 factor 5 excess with spontaneous thrombosis KG + DL
17 beta-thalassemia with other manifestations KG + DL
18 heparin cofactor 2 deficiency KG + DL
19 myocardial infarction KG + DL
20 pyropoikilocytosis, hereditary KG + DL
21 hemolytic anemia due to glucophosphate isomerase deficiency KG + DL
22 posteroinferior myocardial infarction KG + DL
23 posterolateral myocardial infarction KG + DL
24 septal myocardial infarction KG + DL
25 pyruvate kinase deficiency of red cells KG + DL
26 thrombophilia KG + DL
27 hereditary breast ovarian cancer syndrome KG + DL
28 coronary thrombosis KG + DL
29 hypoalphalipoproteinemia KG + DL
30 peripheral vascular disease KG + DL
31 allergic asthma KG + DL
32 stroke disorder KG + DL
33 coronary stenosis KG + DL
34 intermittent vascular claudication KG + DL
35 migraine with or without aura, susceptibility to KG + DL
36 atrophoderma vermiculata KG + DL
37 nipple carcinoma KG + DL
38 rheumatoid arthritis KG + DL
39 breast fibrocystic disease KG + DL
40 obsolete susceptibility to ischemic stroke KG + DL
41 intracranial arteriosclerosis KG + DL
42 intrinsic asthma KG + DL
43 ulerythema ophryogenesis KG + DL
44 resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta KG + DL
45 congenital coronary artery anomaly KG + DL
46 bilateral breast carcinoma KG + DL
47 estrogen-receptor negative breast cancer KG + DL
48 breast carcinoma by gene expression profile KG + DL
49 Ehrlich tumor carcinoma KG + DL
50 hormone-resistant breast carcinoma KG + DL

(Showing top 50 of 74 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.